WO2011009758A3 - Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel - Google Patents

Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel Download PDF

Info

Publication number
WO2011009758A3
WO2011009758A3 PCT/EP2010/060029 EP2010060029W WO2011009758A3 WO 2011009758 A3 WO2011009758 A3 WO 2011009758A3 EP 2010060029 W EP2010060029 W EP 2010060029W WO 2011009758 A3 WO2011009758 A3 WO 2011009758A3
Authority
WO
WIPO (PCT)
Prior art keywords
purine
oligonucleotide
influence
pigmentation process
natural pigmentation
Prior art date
Application number
PCT/EP2010/060029
Other languages
German (de)
English (en)
Other versions
WO2011009758A2 (fr
Inventor
Melanie Giesen
Erik Schulze Zur Wiesche
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP10734959A priority Critical patent/EP2473236A2/fr
Publication of WO2011009758A2 publication Critical patent/WO2011009758A2/fr
Publication of WO2011009758A3 publication Critical patent/WO2011009758A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'une combinaison de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel de la peau et/ou des phanères.
PCT/EP2010/060029 2009-07-23 2010-07-13 Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel WO2011009758A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10734959A EP2473236A2 (fr) 2009-07-23 2010-07-13 Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102009027959 2009-07-23
DE102009027959.8 2009-07-23
DE102009044976.0 2009-09-24
DE102009044976A DE102009044976A1 (de) 2009-07-23 2009-09-24 Verwendung von Purin und/oder einem Purinderivat und mindestens einem Oligonukleotid zur Beeinflussung des natürlichen Pigmentierungsprozesses

Publications (2)

Publication Number Publication Date
WO2011009758A2 WO2011009758A2 (fr) 2011-01-27
WO2011009758A3 true WO2011009758A3 (fr) 2012-06-07

Family

ID=43384057

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/060029 WO2011009758A2 (fr) 2009-07-23 2010-07-13 Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel

Country Status (3)

Country Link
EP (1) EP2473236A2 (fr)
DE (1) DE102009044976A1 (fr)
WO (1) WO2011009758A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009044976A1 (de) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Purin und/oder einem Purinderivat und mindestens einem Oligonukleotid zur Beeinflussung des natürlichen Pigmentierungsprozesses
DE102010043069A1 (de) 2010-10-28 2012-05-03 Henkel Ag & Co. Kgaa Verwendung von Purin und/oder einem Purinderivat und mindestens einer Aminosäure zur Beeinflussung des natürlichen Pigmentierungsprozesses
DE102011077950A1 (de) 2011-06-22 2012-01-19 Henkel Kgaa Verwendung von Purin und/oder einem Purinderivat zur Verminderung von zellulärem oxidativen Stress
DE102011079453A1 (de) 2011-07-20 2012-04-12 Henkel Ag & Co. Kgaa Verwendung von Biochinonen zur Verminderung von zellulärem oxidativen Stress
EP4292581A1 (fr) 2022-06-16 2023-12-20 Bella Aurora Labs, S.A. Composition de repigmentation capillaire

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245527A (ja) * 1985-08-21 1987-02-27 Shiseido Co Ltd 白髪予防、治療剤
WO1991007945A1 (fr) * 1989-11-28 1991-06-13 Lvmh Recherche Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux
US5643556A (en) * 1993-07-07 1997-07-01 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
US20050000040A1 (en) * 2001-10-12 2005-01-06 Beiersdorf Ag Use of one or several substances selected from the group of pyrimidines and purines in cosmetic preparations for coloring hair
US20050208010A1 (en) * 2002-07-10 2005-09-22 L'oreal Genes from Chromosome 3, 5 and 11 involved in premature canities
DE202005001952U1 (de) * 2005-02-06 2006-08-31 Phenion Gmbh & Co. Kg Kosmetische oder pharmazeutische Zubereitungen enthaltend Nukleinsäuren, die zur Ausbildung von stem-loop-Sekundärstrukturen geeignete Sequenzen umfassen
US20070274936A1 (en) * 2003-12-30 2007-11-29 Robin Kurfurst Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
WO2008135169A1 (fr) * 2007-04-27 2008-11-13 Henkel Ag & Co. Kgaa Préparations cosmétiques et/ou pharmaceutiques contenant des acides nucléiques, destinées au traitement de tissus épithéliaux

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3725030A1 (de) 1987-07-29 1989-02-09 Henkel Kgaa Oberflaechenaktive hydroxysulfonate
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
DE102009044976A1 (de) 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Purin und/oder einem Purinderivat und mindestens einem Oligonukleotid zur Beeinflussung des natürlichen Pigmentierungsprozesses

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6245527A (ja) * 1985-08-21 1987-02-27 Shiseido Co Ltd 白髪予防、治療剤
WO1991007945A1 (fr) * 1989-11-28 1991-06-13 Lvmh Recherche Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux
US5643556A (en) * 1993-07-07 1997-07-01 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
US20050000040A1 (en) * 2001-10-12 2005-01-06 Beiersdorf Ag Use of one or several substances selected from the group of pyrimidines and purines in cosmetic preparations for coloring hair
US20050208010A1 (en) * 2002-07-10 2005-09-22 L'oreal Genes from Chromosome 3, 5 and 11 involved in premature canities
US20070274936A1 (en) * 2003-12-30 2007-11-29 Robin Kurfurst Oligonucleotide and the Use Thereof for Modulating an Isoform C Beta-1 Protein-Kinase in the Form of a Skin Depigmentation Agent
DE202005001952U1 (de) * 2005-02-06 2006-08-31 Phenion Gmbh & Co. Kg Kosmetische oder pharmazeutische Zubereitungen enthaltend Nukleinsäuren, die zur Ausbildung von stem-loop-Sekundärstrukturen geeignete Sequenzen umfassen
WO2008135169A1 (fr) * 2007-04-27 2008-11-13 Henkel Ag & Co. Kgaa Préparations cosmétiques et/ou pharmaceutiques contenant des acides nucléiques, destinées au traitement de tissus épithéliaux

Also Published As

Publication number Publication date
DE102009044976A1 (de) 2011-01-27
EP2473236A2 (fr) 2012-07-11
WO2011009758A2 (fr) 2011-01-27

Similar Documents

Publication Publication Date Title
WO2011009759A3 (fr) Utilisation de dihydroquercétine et d'au moins un acide aminé pour influencer positivement le processus de pigmentation naturel
EP2396342A4 (fr) Expression de la protéine mutante ros dans les cancers chez l'être humain
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
HK1170485A1 (zh) -噻唑烷- -酮衍生物及其在癌症治療中的用途
GB2471644B (en) Dolls and doll stands
GB0818990D0 (en) Water-based skin products
AU329314S (en) Comestible
GB0819883D0 (en) Product and uses
AU329313S (en) Comestible
WO2011009758A3 (fr) Utilisation de purine et/ou d'un dérivé de purine et d'au moins un oligonucléotide pour influencer le processus de pigmentation naturel
HK1124779A1 (en) Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing
WO2011009763A3 (fr) Agent cosmétique contenant de la purine et/ou un dérivé de purine et du sclaréol
WO2011035945A3 (fr) Utilisation d'une association de carnitine et/ou d'un dérivé de la carnitine et de purine et/ou d'un dérivé de la purine pour influer sur le processus naturel de pigmentation
IL209220A0 (en) Plant extract and its therapeutic use
AU329315S (en) Comestible
PL2411107T3 (pl) Zestaw z wyrobem do zabawy oraz odpowiedni sposób
EP2345404A4 (fr) Cosmétique et produit cosmétique en forme de stylo
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
WO2011009761A3 (fr) Utilisation de carnitine et de dihydroquercétine pour influencer positivement le processus de pigmentation naturel
WO2012055580A3 (fr) Utilisation de purine et/ou d'un dérivé de purine et d'au moins une biochinone pour influencer le processus de pigmentation naturel
GB0902538D0 (en) Improvvements in or relating to the creation of curved forms
WO2011009756A3 (fr) Utilisation d'au moins un acide nucléique pour influencer le processus de pigmentation naturel
CA118201S (en) Confectionery product
AU322083S (en) Bread roll
AU322084S (en) Bread roll

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2010734959

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE